Adricin Injection
Marketer
Adley Formulations
Salt Composition
Epirubicin (50mg)
Overview Adricin Injection
Adricin Injection treats various blood cancers, as well as cancers affecting the breast, stomach, lung, ovaries, and soft tissues. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used cautiously, either alone or in combination chemotherapy regimens. Dosage and frequency are determined by your physician based on your specific condition and may vary. Strict adherence to your doctor's instructions is vital; incorrect usage or overdose can lead to severe adverse reactions. While benefits may take weeks or months to manifest, discontinue use only under medical guidance. Because Adricin diminishes contraceptive efficacy, reliable birth control is recommended for both men and women during treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, fever, and rash. The drug's reduction of blood cell count increases infection risk, potentially life-threatening. Regular blood tests monitor blood cell counts, as well as kidney, liver, and heart function. Prior to treatment, disclose any liver or heart conditions, and all other medications you are using, as interactions may affect Adricin's efficacy. Pregnant or breastfeeding patients must inform their doctor.
Uses of Adricin Injection
Malignant neoplasm
Major Benefits of Adricin Injection:
Administering this medication will be performed by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Adricin Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Adricin Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Adricin Injection works:
Adricin Injection is a cancer therapeutic agent. Its mechanism of action involves inhibiting topoisomerase II, an enzyme crucial for breast cancer cell DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, ultimately hindering tumor growth and inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Adricin Injection should not be used concurrently with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Adricin Injection during pregnancy poses a confirmed risk to the fetus. Exceptions may be made in life-threatening circumstances where the potential benefits outweigh the known hazards, at the sole discretion of the prescribing physician. Patient consultation with their physician is essential.
Breast feedingUNSAFE
Administering Adricin Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.
DrivingUNSAFE
Administering Adricin Injection may induce adverse reactions impacting driving capabilities. Nausea and vomiting, potential side effects of Adricin Injection, can temporarily compromise driving ability.
KidneySAFE IF PRESCRIBED
Adricin Injection is likely safe for individuals with kidney impairment. Preliminary findings indicate dose modification for Adricin Injection might be unnecessary in such cases. However, physician consultation is recommended. Reduced dosages could be explored for patients exhibiting serum creatinine exceeding 5 mg/dL.
LiverCAUTION
Adricin Injection requires careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Adricin Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Adricin Injection :
NA
Facts to Know About Adricin Injection
| Label | Value |
|---|---|
| Type of Compound | Anthracycline-based drug |
| Addiction potential | None. |
| Type of Medication | Cancer therapies |
| Mechanism of Action | Plant-derived anti-cancer compounds |
3,018 People bought this recently